Joint Impact of Smoking and Metabolic Syndrome on Cardiovascular Disease: A Cohort Study
Smoking and metabolic syndrome interact synergistically to elevate CVD risk, particularly for myocardial infarction. Targeting both factors is essential for CVD prevention.
Authors
- Tetsuya Mizoue (ORCID: https://orcid.org/0000-0002-1198-2228)
- Naoki Gommori
- Hiroko Okazaki (ORCID: https://orcid.org/0000-0002-0669-9639)
- Seitaro Dohi
- Takeshi Kochi (ORCID: https://orcid.org/0000-0002-3411-1070)
- Takayuki Ogasawara (ORCID: https://orcid.org/0000-0002-1657-6907)
- Isamu Kabe
- Maki Konishi
- Tohru Nakagawa
- Huanhuan Hu (ORCID: https://orcid.org/0000-0001-8558-2895)
- Makoto Yamamoto (ORCID: https://orcid.org/0000-0001-7844-331X)
- Toshiaki Miyamoto (ORCID: https://orcid.org/0000-0002-1944-4280)
- Shuichiro Yamamoto
- Toru Honda
- Hiroshi Ide
Institutions
- Yamaha (Japan) (JP)
- Nippon Steel (Japan) (JP)
- Kubota (Japan) (JP)
- Mitsui Chemicals (Germany) (DE)
- National Institute of Occupational Safety and Health (JP)
- Mitsubishi Fuso Truck and Bus (Japan)
- Furukawa Electric (United Kingdom) (GB)
- Hitachi (Japan) (JP)
- Keihin (Japan) (JP)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2025-08-29
- DOI
- https://doi.org/10.5551/jat.65812
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Center for Global Health and Medicine
- Industrial Health Foundation
- Japan Society for the Promotion of Science